Overview


According to FutureWise analysis the market for Fluorescent in Situ Hybridization (FISH) Probe in 2023 is US$ 0.89 billion, and is expected to reach US$ 1.63 billion by 2031 at a CAGR of 7.82%.

Fluorescence in situ hybridization (FISH) is a technique for recognising macromolecules that is considered a novel development in the field of cytology. It was created as a physical mapping tool to delineate genes inside chromosomes. FISH's precision and versatility have since been exploited in biological and medical studies. This aesthetically appealing technique offers a resolution that falls in between DNA analysis and chromosomal studies. A hybridising DNA probe, which can be tagged directly or indirectly, is used in FISH. Direct labelling involves the use of fluorescent nucleotides, whereas indirect labelling involves the use of reporter molecules that are then identified by fluorescent antibodies or other affinity molecules. FISH is used to detect genetic abnormalities such as different types of gene fusions, an aberrant number of chromosomes in a cell, or the loss of a chromosomal region or an entire chromosome. It's also used in a variety of scientific projects, including as gene mapping and the discovery of new oncogenes. The increasing prevalence and rising cases of cancer and genetic disorders are expected to boost the global fluorescent in situ hybridization probes market. FISH takes less time than the traditional method of cytogenetic metaphase karyotype analysis because the former requires no culture and includes processing with either fresh water or paraffin-embedded interphase nuclei. Specific cytogenetic anomalies, as well as a copy of aberration numbers, can be enumerated and sketched using this technique. Prader-Willi syndrome, Angelman syndrome, 22q13 deletion syndrome, chronic myelogenous leukaemia, acute lymphoblastic leukaemia, Cri-du-chat syndrome, Velocardiofacial syndrome, and Down syndrome are all disorders that can be detected with FISH. FISH on sperm cells is recommended for men who have an aberrant somatic or meiotic karyotype, as well as those who have oligozoospermia, because about half of oligozoospermia men have sperm chromosome abnormalities. Individuals with oligozoospermia can be identified by looking at their chromosomes 21, X, and Y. As a result, FISH is becoming an increasingly important method for detecting and monitoring specific therapies for gene anomalies, such as the discovery of the BCR/ALB1 translocation in chronic myeloid leukaemia.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Fluorescent in Situ Hybridization (FISH) Probe Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Fluorescent in Situ Hybridization (FISH) Probe Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Thermo Fisher Scientific
  • PerkinElmer, Inc.
  • Merck KGaA
  • Leica Biosystems Nussloch GmbH
  • Agilent Technologies, Inc.
  • Abnova Corporation
  • Tocris Bioscience
  • LGC Biosearch Technologies
  • Genemed Biotechnologies, Inc.
  • F. Hoffmann-La Roche Ltd
  • Empire Genomics, LLC
  • Oxford Gene Technology
  • Biocare Medical, LLC
  • QIAGEN
  • Abbott
  • Danaher
  • BioGenex Laboratories
  • Biocare Medical
  • Mirus Bio, LLC

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Probe Type

  • Locus Specific Probes
  • Alphoid or Centromeric Repeat Probes
  • Biotechnology Companies

By Technology

  • Q- Fluorescent In Situ Hybridization
  • Flow Fluorescent In Situ Hybridization
  • C- Fluorescent In Situ Hybridization
  • D- Fluorescent In Situ Hybridization
  • Others

By Type

  • DNA
  • RNA

By Application

  • Cancer Research
  • Genetic Diseases
  • Others

By End-Users

  • Research Organizations
  • Clinical Organizations
  • Biotechnology Companies
  • Companion Diagnostics
  • Academic and Research Institutes

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Fluorescent in Situ Hybridization (FISH) Probe Market By Probe Type, By Technology, By Type, By Application, By End-Users and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Fluorescent in Situ Hybridization (FISH) Probe Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Fluorescent in Situ Hybridization (FISH) Probe Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Fluorescent in Situ Hybridization (FISH) Probe Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Fluorescent in Situ Hybridization (FISH) Probe Market, By Probe Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Locus Specific Probes
        2. Alphoid or Centromeric Repeat Probes
        3. Biotechnology Companies

  • 8.   Fluorescent in Situ Hybridization (FISH) Probe Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Q- Fluorescent In Situ Hybridization
        2. Flow Fluorescent In Situ Hybridization
        3. C- Fluorescent In Situ Hybridization
        4. D- Fluorescent In Situ Hybridization
        5. Others

  • 9.   Fluorescent in Situ Hybridization (FISH) Probe Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. DNA
        2. RNA

  • 10.   Fluorescent in Situ Hybridization (FISH) Probe Market, By Applications Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Cancer Research
        2. Genetic Diseases
        3. Others

  • 11.   Fluorescent in Situ Hybridization (FISH) Probe Market, By End-Users Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Research Organizations
        2. Clinical Organizations
        3. Biotechnology Companies
        4. Companion Diagnostics
        5. Academic and Research Institutes

  • 12.   North America Fluorescent in Situ Hybridization (FISH) Probe Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 13.   Latin America Fluorescent in Situ Hybridization (FISH) Probe Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 14.   Europe Fluorescent in Situ Hybridization (FISH) Probe Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 15.   Asia Pacific Fluorescent in Situ Hybridization (FISH) Probe Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 16.   Middle East and Africa Fluorescent in Situ Hybridization (FISH) Probe Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 17.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Thermo Fisher Scientific
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. PerkinElmer, Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Merck KGaA
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Leica Biosystems Nussloch GmbH
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Agilent Technologies, Inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Abnova Corporation
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Tocris Bioscience
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. LGC Biosearch Technologies
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Genemed Biotechnologies, Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. F. Hoffmann-La Roche Ltd
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
         11. Empire Genomics, LLC
          11.1. Company Overview
          11.2. Product Portfolio
          11.3. SWOT Analysis
          11.4. Financial Overview
          11.5. Strategic Overview
         12. Oxford Gene Technology
          12.1. Company Overview
          12.2. Product Portfolio
          12.3. SWOT Analysis
          12.4. Financial Overview
          12.5. Strategic Overview
         13. iocare Medical, LLC
          13.1. Company Overview
          13.2. Product Portfolio
          13.3. SWOT Analysis
          13.4. Financial Overview
          13.5. Strategic Overview
         14. QIAGEN
          14.1. Company Overview
          14.2. Product Portfolio
          14.3. SWOT Analysis
          14.4. Financial Overview
          14.5. Strategic Overview
         15. Abbott
          15.1. Company Overview
          15.2. Product Portfolio
          15.3. SWOT Analysis
          15.4. Financial Overview
          15.5. Strategic Overview
         16. Danaher
          16.1. Company Overview
          16.2. Product Portfolio
          16.3. SWOT Analysis
          16.4. Financial Overview
          16.5. Strategic Overview
         17. BioGenex Laboratories
          17.1. Company Overview
          17.2. Product Portfolio
          17.3. SWOT Analysis
          17.4. Financial Overview
          17.5. Strategic Overview
          18. Biocare Medical
          18.1. Company Overview
          18.2. Product Portfolio
          18.3. SWOT Analysis
          18.4. Financial Overview
          18.5. Strategic Overview
         19. Mirus Bio, LLC
          19.1. Company Overview
          19.2. Product Portfolio
          19.3. SWOT Analysis
          19.4. Financial Overview
          19.5. Strategic Overview

  • 19.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 20.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients